Cargando…
Therapy of Non-Dermatophytic Mycoses in Animals
This review focuses on aspects of antimycotic therapy specific to veterinary medicine. In the first part, drug availability, limited mostly by economic consideration but also by clinical applicability and specific adverse effects, is described for polyenes, 5 fluorocytosine, azoles, echinocandins an...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308939/ https://www.ncbi.nlm.nih.gov/pubmed/30380772 http://dx.doi.org/10.3390/jof4040120 |
_version_ | 1783383306046275584 |
---|---|
author | Elad, Daniel |
author_facet | Elad, Daniel |
author_sort | Elad, Daniel |
collection | PubMed |
description | This review focuses on aspects of antimycotic therapy specific to veterinary medicine. In the first part, drug availability, limited mostly by economic consideration but also by clinical applicability and specific adverse effects, is described for polyenes, 5 fluorocytosine, azoles, echinocandins and terbinafine. In the second part, current knowledge and experience in the treatment of selected fungal infections are overviewed. These mycoses include disseminated mold infections in small animals (dogs and cats) and avian species, upper respiratory tract infections of small animals (sino-nasal and sino-orbital aspergillosis) and horses (guttural pouch mycosis), eumycetoma, infections caused by dimorphic fungi, (blastomycosis, histoplasmosis, coccidioidomycosis, paracoccidioidomycosis and sporothrichosis) and by yeasts and yeast-like microorganism (Cryptococcus spp. and Malassezia pachydermatis). |
format | Online Article Text |
id | pubmed-6308939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63089392019-06-17 Therapy of Non-Dermatophytic Mycoses in Animals Elad, Daniel J Fungi (Basel) Review This review focuses on aspects of antimycotic therapy specific to veterinary medicine. In the first part, drug availability, limited mostly by economic consideration but also by clinical applicability and specific adverse effects, is described for polyenes, 5 fluorocytosine, azoles, echinocandins and terbinafine. In the second part, current knowledge and experience in the treatment of selected fungal infections are overviewed. These mycoses include disseminated mold infections in small animals (dogs and cats) and avian species, upper respiratory tract infections of small animals (sino-nasal and sino-orbital aspergillosis) and horses (guttural pouch mycosis), eumycetoma, infections caused by dimorphic fungi, (blastomycosis, histoplasmosis, coccidioidomycosis, paracoccidioidomycosis and sporothrichosis) and by yeasts and yeast-like microorganism (Cryptococcus spp. and Malassezia pachydermatis). MDPI 2018-10-30 /pmc/articles/PMC6308939/ /pubmed/30380772 http://dx.doi.org/10.3390/jof4040120 Text en © 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Elad, Daniel Therapy of Non-Dermatophytic Mycoses in Animals |
title | Therapy of Non-Dermatophytic Mycoses in Animals |
title_full | Therapy of Non-Dermatophytic Mycoses in Animals |
title_fullStr | Therapy of Non-Dermatophytic Mycoses in Animals |
title_full_unstemmed | Therapy of Non-Dermatophytic Mycoses in Animals |
title_short | Therapy of Non-Dermatophytic Mycoses in Animals |
title_sort | therapy of non-dermatophytic mycoses in animals |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308939/ https://www.ncbi.nlm.nih.gov/pubmed/30380772 http://dx.doi.org/10.3390/jof4040120 |
work_keys_str_mv | AT eladdaniel therapyofnondermatophyticmycosesinanimals |